LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry

Abstract Limbic-predominant age-related TDP-43 encephalopathy (LATE) affects approximately one-third of older individuals and is associated with cognitive impairment. However, there is a highly incomplete understanding of the genetic determinants of LATE neuropathologic changes (LATE-NC) in diverse populations. The defining neuropathologic feature of LATE-NC is TDP-43 proteinopathy, often with comorbid hippocampal sclerosis (HS). In terms of genetic risk factors, LATE-NC and/or HS are associated with single nucleotide variants (SNVs) in 3 genes—TMEM106B (rs1990622), GRN (rs5848), and ABCC9 (rs1914361 and rs701478). We evaluated these 3 genes in convenience samples of individuals of African ancestry. The allele frequencies of the LATE-associated alleles were significantly different between persons of primarily African (versus European) ancestry: In persons of African ancestry, the risk-associated alleles for TMEM106B and ABCC9 were less frequent, whereas the risk allele in GRN was more frequent. We performed an exploratory analysis of data from African-American subjects processed by the Alzheimer’s Disease Genomics Consortium, with a subset of African-American participants (n = 166) having corroborating neuropathologic data through the National Alzheimer’s Coordinating Center (NACC). In this limited-size sample, the ABCC9/rs1914361 SNV was associated with HS pathology. More work is required concerning the genetic factors influencing non-Alzheimer disease pathology such as LATE-NC in diverse cohorts.

[1]  C. DeCarli,et al.  TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups. , 2023, Journal of Alzheimer's disease : JAD.

[2]  Janna H. Neltner,et al.  LATE-NC staging in routine neuropathologic diagnosis: an update , 2022, Acta Neuropathologica.

[3]  R. Buchert,et al.  Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[4]  Caitlin P. McHugh,et al.  Recommendations on the use and reporting of race, ethnicity, and ancestry in genetic research: Experiences from the NHLBI TOPMed program , 2022, Cell genomics.

[5]  Janna H. Neltner,et al.  Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts , 2022, Acta Neuropathologica.

[6]  J. Masdeu,et al.  Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies , 2022, Acta Neuropathologica.

[7]  C. Ferri,et al.  Attenuated effect of the apolipoprotein E ɛ4 allele on neuropsychiatric symptoms among African older adults , 2021, International Psychogeriatrics.

[8]  Kevin L. Boehme,et al.  Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy , 2020, Acta Neuropathologica.

[9]  D. Bennett,et al.  Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents , 2020, Neurology.

[10]  T. A. Alexander,et al.  LDpop: an interactive online tool to calculate and visualize geographic LD patterns , 2020, BMC Bioinformatics.

[11]  Alex Diaz-Papkovich,et al.  UMAP reveals cryptic population structure and phenotype heterogeneity in large genomic cohorts , 2019, PLoS genetics.

[12]  C. Jack,et al.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report , 2019, Brain : a journal of neurology.

[13]  C. DeCarli,et al.  Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center. , 2019, Journal of Alzheimer's Disease.

[14]  Brian E. Cade,et al.  Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program , 2019, Nature.

[15]  Kevin F. Bieniek,et al.  Ethnoracial differences in Alzheimer’s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort , 2019, Alzheimer's & Dementia.

[16]  Charles C. White,et al.  Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study , 2018, The Lancet Neurology.

[17]  Y. Asmann,et al.  TMEM106B haplotypes have distinct gene expression patterns in aged brain , 2018, Molecular Neurodegeneration.

[18]  Clifford R. Jack,et al.  The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable , 2018, Alzheimer's & Dementia.

[19]  Sally R. Ellingson,et al.  Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2 , 2017, Neurobiology of Aging.

[20]  D. Bennett,et al.  Genetic architecture of age-related cognitive decline in African Americans , 2016, Neurology: Genetics.

[21]  Derek J Van Booven,et al.  ABCA7 frameshift deletion associated with Alzheimer disease in African Americans , 2016, Neurology: Genetics.

[22]  Kevin L. Boehme,et al.  Assessment of the genetic variance of late-onset Alzheimer's disease , 2016, Neurobiology of Aging.

[23]  L. Grinberg,et al.  Higher Prevalence of TDP‐43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample , 2016, Brain pathology.

[24]  Timothy J. Hohman,et al.  Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk , 2016, Alzheimer's & Dementia.

[25]  Mitchell J. Machiela,et al.  LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..

[26]  S. Leurgans,et al.  Hippocampal sclerosis and TDP‐43 pathology in aging and Alzheimer disease , 2015, Annals of neurology.

[27]  David Reich,et al.  The Genetic Ancestry of African Americans, Latinos, and European Americans across the United States , 2015, American journal of human genetics.

[28]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[29]  Margaret A. Pericak-Vance,et al.  Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias , 2014, PLoS genetics.

[30]  M. Murray,et al.  Differential clinicopathologic and genetic features of late-onset amnestic dementias , 2014, Acta Neuropathologica.

[31]  Charles D. Smith,et al.  ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology , 2014, Acta Neuropathologica.

[32]  P. Crane,et al.  Alzheimer’s Disease: Analyzing the Missing Heritability , 2013, PloS one.

[33]  Christine Haberler,et al.  Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series , 2013, Acta Neuropathologica.

[34]  Oscar L Lopez,et al.  Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. , 2013, JAMA.

[35]  Iuliana Ionita-Laza,et al.  Scan-statistic approach identifies clusters of rare disease variants in LRP2, a gene linked and associated with autism spectrum disorders, in three datasets. , 2012, American journal of human genetics.

[36]  L. Grinberg,et al.  African ancestry protects against Alzheimer's disease-related neuropathology , 2011, Molecular Psychiatry.

[37]  P. Sham,et al.  Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases , 2011, Genetic epidemiology.

[38]  L. Park Identifying disease polymorphisms from case–control genetic association data , 2010, Genetica.

[39]  D. Dickson,et al.  Common Variant in GRN Is a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly , 2010, Neurodegenerative Diseases.

[40]  Charles D. Smith,et al.  Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons , 2010, Brain pathology.

[41]  R. Petersen,et al.  Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia , 2008, Human molecular genetics.

[42]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[43]  D. Dickson,et al.  TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.

[44]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[45]  J. Ott,et al.  Power and Sample Size Calculations for Case-Control Genetic Association Tests when Errors Are Present: Application to Single Nucleotide Polymorphisms , 2002, Human Heredity.

[46]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[47]  R. Green,et al.  Risk of dementia among white and African American relatives of patients with Alzheimer disease. , 2002, JAMA.

[48]  O. Gureje,et al.  Apolipoprotein E—associated risk for Alzheimer's disease in the African‐American population is genotype dependent , 1997, Annals of neurology.

[49]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[50]  F. Schmitt,et al.  Challenges and Considerations Related to Studying Dementia in Blacks/African Americans. , 2017, Journal of Alzheimer's disease : JAD.

[51]  M. Murray,et al.  Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A , 2014, Acta Neuropathologica.

[52]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[53]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.